-
The Evolution of Language in Clinical Outcome Assessments- An Analysis of Source Wording Updates, Translation Updates, and the Need to Periodically Assess the Revelance of Linguistically Validated Translations
Mar 10, 2025, 14:00 PM -
Algeria's Healthcare System in 2024: Progress Against Persisting Challenges
Mar 10, 2025, 14:00 PM -
Evolving Real-world Trends in Biomarker Testing for Bladder Cancer: A Comprehensive Retrospective Analysis from the US Community Oncology Setting (2015-2024)
Mar 10, 2025, 14:00 PM -
Belantamab Mafodotin, Pomalidomide, and Dexamethasone (BPd) in Relapsed/Refractory Multiple Myeloma (RRMM): Quality-Adjusted Life-Year (QALY) Results From a Cost-Effectiveness Model
Mar 10, 2025, 14:00 PM -
Tremor Symptoms and Associated Activities of Daily Living Impacts in Essential Tremor: A Qualitative Concept Elicitation and Mapping Study
Mar 10, 2025, 14:00 PM -
Study of Patient Preferences Regarding a New Class of Antihypertensive Medications: A Discrete Choice Experiment in Ukraine
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Gabapentin, Pregabalin, and Duloxetine in the Treatment of Painful Diabetic Neuropathy: A Real-World Data-Based Net Benefit Regression Analysis
Mar 10, 2025, 14:00 PM -
Aggressive End-of-Life Care among Non-Small Cell Lung Cancer Medicare Patients
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pegfilgrastim Versus 5-day Filgrastim in Early Breast Cancer Patients Undergoing Neoadjuvant and Adjuvant Chemotherapy: A Trial-Based Economic Evaluation
Mar 10, 2025, 14:00 PM -
Characterizing Post-Pandemic Social Determinants of Health of the Population Testing for COVID-19 in a Nationwide Network in the United States
Mar 10, 2025, 14:00 PM -
Assessing the Accuracy of Artificial Intelligence in Conducting Systematic Literature Reviews
Mar 10, 2025, 14:00 PM -
Developing a Conceptual Framework for a De-novo Cost-Effectiveness Model in Sanfilippo Syndrome (MPSIIIA)
Mar 10, 2025, 14:00 PM -
Role of Relative Dose Intensity in Health Economic Evaluations: A Review of National Institute for Health and Care Excellence Technology Appraisals of Treatments in Solid Tumors
Mar 10, 2025, 14:00 PM -
Epidemiology of Polymyalgia Rheumatica: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Estimating the Magnitude of a Pull Incentive for Antibiotic Development Using the STEDI Value Framework: An Example From Spain
Mar 10, 2025, 14:00 PM -
Preparing for German Health Technology Assessment: Analysis of Factors Associated with the Risk of Having Inappropriate Comparator
Mar 10, 2025, 14:00 PM -
Early Breast Cancer in the US and Germany: A Comparison of Real-world Screening and Treatment
Mar 10, 2025, 14:00 PM -
Artificial Intelligence Software as a Medical Device: Regulatory Approvals and Post-Deployment Evaluation Frameworks in North America and Europe
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Among Ticagrelor-Treated Patients With Bleeding or Undergoing Urgent Surgery in the United States: A Real-World, Retrospective Claims Analysis
Mar 10, 2025, 14:00 PM -
Real-World Impact Of Recurrence On Overall Survival (OS) In Patients With Unresectable Locally Advanced (LA) Esophageal/Gastroesophageal Junction Cancer (EC/GEJC) Treated With Definitive Chemoradiotherapy (dCRT) In US Community Oncology Clinics
Mar 10, 2025, 14:00 PM
